Paige Chamberlain
Stock Analyst at Wolfe Research
(2.35)
# 3,078
Out of 4,501 analysts
5
Total ratings
100%
Success rate
26.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paige Chamberlain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Rated: Buy | $55 | $56.97 | -3.46% | 1 | Jun 1, 2026 | |
| NTRA Natera | Rated: Buy | $260 | $269.95 | -3.69% | 1 | Jun 1, 2026 | |
| GH Guardant Health | Rated: Buy | $150 | $160.05 | -6.28% | 1 | Jun 1, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | n/a | $72.00 | - | 1 | Jun 1, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | n/a | $58.23 | - | 1 | Jun 1, 2026 |
Veracyte
Jun 1, 2026
Rated: Buy
Price Target: $55
Current: $56.97
Upside: -3.46%
Natera
Jun 1, 2026
Rated: Buy
Price Target: $260
Current: $269.95
Upside: -3.69%
Guardant Health
Jun 1, 2026
Rated: Buy
Price Target: $150
Current: $160.05
Upside: -6.28%
GRAIL
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $72.00
Upside: -
Tempus AI
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $58.23
Upside: -